Research
Cellular
Systematic screening for advanced fibrosis related to MASLD is recommended for patients with T2D.
Healthcare professionals should implement systematic screening for liver fibrosis in diabetic patients.
StrongSupportsmedium confidence
MASLD-related liver fibrosis is a major driver of hepatic complications and is associated with increased risk of extrahepatic complications, such as cardiovascular and renal diseases in patients with T2D.
Why this rating
The claim is based on expert consensus and the prevalence of the conditions.
Source
Management of patients with type 2 diabetes and MASLD: An overview and joint statement
Yasmina Chouik et al. · Diabetes & Metabolism · 2025
DOI 10.1016/j.diabet.2025.101709
reviewCited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- The management of MASLD in patients with T2D includes dietary and behavioral management, pharmacological treatment, and bariatric procedures.Strong
- The goal of management in T2D patients with significant fibrosis is to slow the progression of liver disease and reduce associated clinical events.Strong
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →